Polycystic kidney disease management
Ongoing specialist care for an inherited condition in which cysts grow in the kidneys, aiming to protect kidney function and manage symptoms and family risk.
✓ Medically reviewed by a GMC-registered consultant · last reviewed September 2026 · next review September 2027 · how we review
In short
- ADPKD is an inherited condition with no cure; management aims to slow decline and manage complications.
- Good blood pressure control is one of the most important things you can do to protect your kidneys.
- Tolvaptan can slow cyst growth for some people with rapidly progressing disease, but it has significant side effects and strict eligibility.
- It is a family condition: each child of an affected parent has a one in two chance of inheriting it, so screening and genetic advice matter.
A plain-English summary. The detail — including risks and recovery — is below.
At a glance
A general guide. Your specialist will give you advice for your situation.
Slows kidney decline through good blood pressure control and, in selected people, tolvaptan.
Tolvaptan is not suitable for everyone; it is reserved for selected adults with evidence of rapidly progressing disease who can tolerate the side effects...
The condition is confirmed and explained, blood pressure and kidney function are assessed, and family implications are discussed.
Lifelong, coordinated monitoring of kidney function and blood pressure, with liver tests if on tolvaptan.
The condition is confirmed and explained, blood pressure and kidney function are assessed, and family implications...
Blood pressure treatment is optimised and symptoms addressed. If rapidly progressing disease is suspected...
Treatment begins with dose adjustment and regular liver blood tests; you adapt to increased thirst and urination.
Regular reviews track kidney function and blood pressure, watch for complications, and adjust treatment.
What is polycystic kidney disease management?
Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited kidney disease. Fluid-filled cysts grow in the kidneys over many years, gradually enlarging them and, in many people, slowly reducing kidney function. Because it is inherited in an autosomal dominant pattern, each child of an affected parent has a one in two chance of inheriting it.
Management is the lifelong specialist care that follows diagnosis. There is no cure. Care focuses on protecting kidney function (especially good blood pressure control), managing symptoms such as pain, blood in the urine and infections, watching for complications, and — for some people whose disease is progressing quickly — a medicine called tolvaptan that can slow cyst growth. It also includes discussing what the diagnosis means for your family.
The aim is to slow decline, manage problems early and support you and your family in making informed decisions, including about genetic testing and screening. It cannot stop the cysts forming or guarantee you will avoid kidney failure.
Types, options & approaches
There may be different ways to do this. The right approach depends on the clinical question and your circumstances.
General management vs tolvaptan
| General management | Tolvaptan | |
|---|---|---|
| Who it is for | Everyone with ADPKD | Selected, rapidly progressing disease |
| Main aim | Protect kidneys, manage symptoms | Slow cyst growth and function decline |
| Key measures | Blood pressure control, symptom care | Daily medicine with monitoring |
| Main trade-off | Few risks | Excess thirst, frequent urination, liver monitoring |
Tolvaptan is added to, not a replacement for, good general management, and only when eligibility criteria are met.
Preparing for your treatment
- Bring your diagnosis details and any genetic test or family history information.
- Bring a full list of your medicines, including blood pressure treatment and painkillers.
- Note your recent blood pressure readings if you monitor at home.
- List symptoms such as pain, blood in the urine, infections or headaches.
- Mention family members affected, and whether relatives want information about screening.
- Tell the team if you are planning a pregnancy, as this affects medicines including tolvaptan.
- Bring previous kidney-function results and scan reports to show the trend.
What happens
A kidney specialist (nephrologist) confirms the diagnosis — usually from ultrasound and family history, sometimes with genetic testing — and assesses how the disease is behaving. They check your blood pressure, kidney function and for complications, and explain what the condition means for you and your family.
Management is then tailored. Blood pressure is treated, often with an ACE inhibitor or ARB. Symptoms such as pain, infections and blood in the urine are managed as they arise. If your disease appears to be progressing quickly and you meet the criteria, tolvaptan may be discussed; this involves an honest conversation about its benefits, its side effects (notably marked thirst and passing large amounts of urine) and the need for regular liver blood tests.
You are then followed long term, with regular tests and reviews, surveillance for complications, and support around family screening and, if needed, planning for advanced kidney disease.
Is this treatment right for me?
A good consultation should explore whether it's the right choice for you now — including reasons to wait or consider something else.
May not be suitable if…
- Tolvaptan is not suitable for everyone; it is reserved for selected adults with evidence of rapidly progressing disease who can tolerate the side effects and monitoring.
- No treatment cures ADPKD, so anything promising a cure is not credible.
- Stand-alone private care may not suit advanced disease, which usually needs an NHS kidney unit for transplant or dialysis planning.
- Tolvaptan is generally avoided in pregnancy and breastfeeding and where liver problems make it unsafe.
Delay or rearrange if…
- You have a current kidney or cyst infection that needs treating first.
- You are pregnant or planning pregnancy, as tolvaptan and some other medicines are unsafe and the plan must be reviewed.
- You have unstable symptoms such as a severe headache or heavy bleeding — these need urgent assessment rather than routine delay.
- Liver blood tests are abnormal, which can delay or prevent starting tolvaptan.
Alternatives to discuss
- Good general management (blood pressure control, symptom care, monitoring) without tolvaptan, especially if the disease is not rapidly progressing or tolvaptan is not tolerated.
- Watchful monitoring with lifestyle measures and hydration.
- Standard NHS nephrology care, often shared even when some appointments are private.
- Planning for transplant, ideally before dialysis is needed, in advanced disease.
Before you decide
Use this as a shared-decision checklist. The aim is not just “can this be done?”, but whether it is right for you, now, with the risks and alternatives clearly understood.
What matters most to me?
Think about symptoms, daily life, work, caring responsibilities, sport, fertility, travel, appearance and anxiety — the right choice depends on your priorities, not just the medical facts.
What are all my options?
Ask about waiting, monitoring, medicines, rehabilitation, a smaller or larger procedure, a different test, NHS referral, or a second opinion where that would help.
What would make me pause?
Active infection, pregnancy, unstable medical problems, smoking, medicines that increase bleeding, poor support at home, or feeling pressured are all reasons to slow down and get tailored advice.
What happens if I do nothing today?
For some problems, waiting is safe; for others, delay can make treatment harder. A good consultation should explain the trade-off in plain English.
Benefits
- Slows kidney decline through good blood pressure control and, in selected people, tolvaptan.
- Manages painful or distressing complications such as infections, stones and blood in the urine.
- Detects and addresses complications early through regular monitoring.
- Supports informed decisions about genetic testing and screening of relatives.
- Allows timely planning for dialysis or, often preferably, a transplant if kidneys fail.
- Coordinates care for associated problems, such as liver cysts or, in some families, brain aneurysms.
Risks & complications
- Side effects of blood pressure medicines, such as a cough, dizziness or blood-test changes.
- With tolvaptan: marked thirst and passing large amounts of urine, day and night, which many find hard to live with.
- The need for lifelong monitoring, frequent tests and scans.
- Kidney or cyst infections that can be difficult to treat.
- Kidney stones and episodes of blood in the urine.
- With tolvaptan: liver problems, which is why regular liver blood tests are essential.
- A bleed from a brain aneurysm, which is why screening is offered to some people, especially with a family history.
- Serious liver injury from tolvaptan, requiring it to be stopped.
- Progression to kidney failure needing dialysis or a transplant despite treatment.
ADPKD is lifelong and progressive for many people, and management slows rather than stops it. Tolvaptan is helpful for some but is not a cure, has demanding side effects (especially thirst and frequent urination) and needs regular liver monitoring, so the decision should be made carefully and honestly. The family nature of the condition also raises difficult choices about testing relatives. Ask your nephrologist whether your disease is progressing quickly, whether tolvaptan is right for you, and what screening your family should consider.
Published figures to discuss
ADPKD progresses at very different rates between individuals and families, so single figures for time to kidney failure are not reliable for any one person. Tolvaptan reduces the rate of kidney-function decline and cyst growth in clinical trials of people with rapidly progressing disease, but the benefit is a slowing of decline rather than a halt or reversal, and it must be weighed against side effects and the need for liver monitoring. The clearest figure to share is the inheritance risk; treatment effects should be discussed individually with your nephrologist.
| Figure | Reported range | How to interpret it | Source / confidence |
|---|---|---|---|
| Chance a child of an affected parent inherits ADPKD | 1 in 2 (50%) | ADPKD is inherited in an autosomal dominant pattern; this underpins family screening and genetic counselling. | NHS — Autosomal dominant polycystic kidney diseasenhs.ukPublished figure |
| Progression to kidney failure | Highly variable by genotype, kidney size, age and blood pressure | Some people never need kidney replacement therapy; others progress earlier and need risk-stratified follow-up. | NHS — Autosomal dominant polycystic kidney diseasenhs.ukSource-linked context |
| Tolvaptan side effects | Common thirst/urination; rare liver injury | NICE-approved use requires suitability assessment and regular liver blood-test monitoring. | NICE TA358 — Tolvaptan for treating ADPKDnice.org.ukSource-linked context |
| Brain aneurysm screening not individualised | Family-history dependent | Screening is usually targeted to people with relevant family history, previous aneurysm or high-risk circumstances. | NHS — Autosomal dominant polycystic kidney diseasenhs.ukSource-linked context |
These are literature figures, not a personalised prediction. Your own risks and likely benefits depend on your circumstances, your health, and how your care is carried out and followed up.
What happens afterwards
ADPKD is managed over a lifetime rather than recovered from. 'Afterwards' means how your kidneys behave over years, how complications are handled, and how treatment is monitored and adjusted.
- Slow change in kidney function and cyst size over years, not sudden change.
- Adjusting to lifelong medicines and regular monitoring.
- On tolvaptan, drinking and passing much more fluid than before.
- Occasional episodes of pain, infection or blood in the urine that are managed as they arise.
Aftercare
- Take blood pressure and other medicines exactly as prescribed and attend monitoring.
- Keep your blood pressure well controlled, including any home monitoring requested.
- If on tolvaptan, drink to thirst, keep to the liver blood-test schedule, and report any sign of liver trouble.
- Stay well hydrated generally and be cautious with anti-inflammatory painkillers, which can harm the kidneys.
- Report symptoms of kidney or cyst infection, kidney stones or blood in the urine promptly.
- Discuss family screening and genetic counselling, and plan ahead before any pregnancy.
- Attend regular reviews so kidney function, complications and treatment can be tracked.
- Seek urgent help for a sudden severe headache, which could signal a brain aneurysm bleed.
- Diagnosis and any genetic test results to hand
- Up-to-date medicines list
- Home blood pressure readings if monitored
- Record of kidney-function results and scans
- Notes on symptoms such as pain or infections
- Family screening questions noted
- Pregnancy plans discussed if relevant
⚠ Get urgent help if…
- Sudden, severe headache, or the worst headache of your life — seek emergency help (possible aneurysm bleed).
- High fever with kidney pain, suggesting a kidney or cyst infection.
- Heavy or persistent blood in the urine.
- Severe loin or abdominal pain.
- Signs of possible liver problems on tolvaptan: nausea, loss of appetite, yellowing skin or eyes, dark urine.
- A sudden drop in urine output or rapidly worsening swelling.
- Feeling very unwell, drowsy or confused.
Who to contact: your clinician, clinic or test provider first (keep their number to hand). For urgent advice when you can't reach them, call NHS 111. In an emergency, call 999.
General guidance — it doesn't replace the specific advice your specialist gives you.
Results & realistic expectations
A good outcome is well-controlled blood pressure, complications managed early, and kidney function preserved for as long as possible. For people on tolvaptan who tolerate it, the aim is to slow cyst growth and the decline in kidney function, though it does not stop the disease.
Management cannot cure ADPKD or guarantee you will avoid kidney failure. Its value is in slowing decline, handling problems early, supporting family decisions, and planning ahead so that, if kidneys do fail, transplant or dialysis is arranged in good time.
ADPKD progresses at very different rates between people and families. Many reach kidney failure at some point in adult life, while others keep reasonable kidney function for decades. Good blood pressure control, and tolvaptan for those eligible, can slow progression but not halt it. Because the course is long and variable, lifelong monitoring and forward planning are central to management.
Related tests, treatments or support
Management often combines kidney care with treatment of high blood pressure and cardiovascular risk, management of liver cysts, and, in some families, screening for brain aneurysms. It links closely with investigation of blood and protein in the urine, and with planning for dialysis or transplant in advanced disease. Genetic counselling connects care for you with screening and advice for your relatives.
Follow-up & long-term care
You are followed in a kidney clinic for life, with regular blood pressure checks, kidney-function blood tests and periodic scans, plus liver blood tests if you are on tolvaptan. Reviews also cover family screening, pregnancy planning and, as kidney function falls, preparation for transplant or dialysis. You should be told who to contact between appointments and which symptoms need urgent care.
- Keep blood pressure tightly controlled and take medicines as prescribed.
- Attend regular kidney-function tests and scans for life.
- If on tolvaptan, keep strictly to the liver blood-test schedule.
- Stay well hydrated and avoid regular anti-inflammatory painkillers unless agreed.
- Keep up genetic and family screening discussions as relatives reach adulthood.
- Review all medicines, including tolvaptan, before any planned pregnancy.
Repeat, follow-on and what comes next
- Tolvaptan may need stopping if side effects or liver blood-test changes make it unsafe or intolerable.
- Blood pressure and other treatments are adjusted over time as kidney function changes.
- Complications such as infections, stones and bleeding are managed as they recur.
- As kidney function declines, the plan shifts towards preparing for transplant or dialysis.
Ask what happens if the result is unclear or needs repeating, and what is included if further tests or follow-up are needed.
What good aftercare looks like
- Lifelong, coordinated monitoring of kidney function and blood pressure, with liver tests if on tolvaptan.
- Honest, shared decision-making about tolvaptan, including stopping rules.
- Access to genetic counselling and family screening, and pre-pregnancy review of medicines.
- A named contact, clear warning signs (including sudden severe headache), and timely planning for transplant or dialysis.
What affects the cost
Costs vary a great deal between people and providers, and we don't publish prices. What matters is understanding what drives the cost and making sure your quote is complete. The main things that affect it:
- Number and length of specialist consultations over a lifetime of care.
- Regular blood and urine tests and periodic scans to track the disease.
- Medicines, including blood pressure treatment and, where eligible, tolvaptan.
- The intensive liver-function monitoring that tolvaptan requires.
- Any genetic testing and counselling for you and your family.
- Management of complications and, in advanced disease, planning for transplant or dialysis.
- The nephrologist consultation fee, including ongoing follow-up.
- Laboratory fees for regular blood and urine tests and for scans.
- Cost of medicines, and specifically the monitoring tolvaptan requires.
- Cost of any genetic testing and counselling.
- Whether family screening is included or charged separately.
- What happens, and what it costs, as the disease progresses and needs more treatment or planning for transplant or dialysis.
On the NHS? ADPKD is managed by NHS kidney units, including tolvaptan for those who meet NICE criteria; private nephrology is sometimes used for a faster appointment, choice of specialist or a second opinion, though complex and long-term care is usually shared with an NHS unit.
You're entitled to your total cost in writing — including reports, follow-up and what happens if the result is inconclusive — before you decide.
Consent traps and marketing red flags
These are not small details. They are often where patients lose choice, time to reflect, or realistic expectations.
Consent traps
- Starting tolvaptan without an honest discussion of thirst, frequent urination and mandatory liver monitoring.
- Implying ADPKD can be cured or that tolvaptan halts the disease.
- Not discussing the family and genetic implications, including effects on relatives and insurance.
- No clear plan for monitoring, complications, pregnancy and advanced-disease planning.
Marketing red flags
- Claims that a diet, supplement or 'cleanse' can shrink cysts or cure ADPKD.
- Overselling tolvaptan as a cure rather than a treatment that slows decline in selected people.
- Offering tolvaptan without the eligibility assessment and liver monitoring NICE requires.
- Genetic testing sold without proper counselling about its implications.
Choosing a specialist safely
- Check the specialist is on the GMC Specialist Register for this area.
- Make sure they work at a CQC-registered service, and look for membership of the relevant Royal College or professional body.
- You're entitled to time to consider and to have your questions answered before you agree — the specialist who looks after you should explain it, not a salesperson.
- Be wary of pressure: time-limited offers or deposits taken before you've had time to think are red flags, not bargains.
- You're entitled to your total cost in writing — including any follow-up — before you decide.
Questions to ask your medical professional
Take this to your consultation. A good specialist will welcome every one of these.
- Is my disease progressing quickly, and how do you judge that?
- Am I eligible for tolvaptan, and honestly, what are its benefits and side effects for me?
- What blood pressure target should I aim for, and which medicine is best for me?
- What should my family know, and how do we arrange genetic counselling or screening?
- Should I be screened for a brain aneurysm?
- How will we plan ahead if my kidney function declines towards needing a transplant or dialysis?
- Are you on the GMC Specialist Register for this area, and which Royal College or professional body are you a member of?
- Will you be the specialist who carries out my treatment, and who looks after me afterwards?
- What are the risks for someone like me, and how often do your own patients have a problem or need it repeated or redone?
- What does a realistic result look like — and what can this treatment not achieve?
- What are my options, including waiting, doing nothing for now, or choosing a different approach?
- Can I have written information, results and aftercare instructions in a format I can use, including any accessibility or communication support I need?
- What is the total cost in writing, including any follow-ups, and how much time do I have to decide?
Frequently asked questions
Can polycystic kidney disease be cured?
What is tolvaptan, and will it help me?
Will my children inherit it?
Should my relatives be screened?
Why might I be offered a brain scan?
Will I need dialysis or a transplant?
Find a verified specialist for polycystic kidney disease management
Every consultant is GMC-checked and independently reviewed. Search by postcode and distance, or switch to a map. Ordered by rating, relevance and recency — never by who pays.
No verified consultants list this procedure yet — browse the full directory.
How we made this page
Medically reviewed by a GMC-registered consultant. Written in plain English, checked against NHS, NICE, GMC and relevant Royal College / specialist-society guidance, and kept under review. No clinic paid to appear on this page, and we publish no pricing. This is general information to help you prepare — it is not a substitute for advice from your own clinician. How we review our guides →
Source hierarchy: UK regulator and NHS/NICE guidance first, then relevant Royal College or specialist-society guidance, then peer-reviewed evidence for procedure-specific figures where available.
Sources & standards: NHS — Autosomal dominant polycystic kidney disease NHS — ADPKD: treatment NICE TA358 — Tolvaptan for treating ADPKD UK Kidney Association — Tolvaptan for ADPKD: guidance commentary (update) Kidney Care UK — Autosomal dominant polycystic kidney disease (ADPKD) PKD Charity (UK)
Reviews reflect patients' experience of care, not clinical outcomes. For procedure volumes and outcome data see PHIN.
Last medically reviewed 2026-09-21. Spotted something wrong or out of date? Report an error in this guide.
Related guides: Glomerulonephritis management · Protein in urine (proteinuria) investigation · Blood in urine (haematuria) investigation · Kidney stone prevention and assessment · Acute kidney injury treatment